Skip to main content
Clinical Trials/NCT06648980
NCT06648980CompletedNot Applicable

Effect of a Nutritional Supplement With Phytoglycogen on Gut-brain Axis With Focus to Perceived Stress, Mood and Sleep: a Randomized, Double-blind, Placebo-controlled Study

Mibelle AG1 site in 1 country72 target enrollmentStarted: November 4, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Mibelle AG
Enrollment
72
Locations
1
Primary Endpoint
Impact on perceived stress (PSQ20)

Study Overview

Brief Summary

Aim of the study is to investigate the effects of a 8-week supplementation of a phytoglycogen on perceived stress, sleep, mood and emotional wellbeing. Additionally, stress-related biomarker will be evaluated.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Women and men
  • •BMI ≥ 19 and ≤ 30 kg/m²
  • •Subject is in good physical and mental health as established by medical history, physical examination, vital signs, results of biochemistry, haematology
  • •PSQ20 total score ≥33
  • •Capable and willing to give written informed consent

Exclusion Criteria

  • •Relevant history or presence of any severe medical disorder, potentially interfering with this study (e.g. mal absorption, chronic gastro-intestinal diseases (colitis ulcerosa, Crohn's IBS, peptic ulcers, celiac disease), depression, diabetes, heavy liver disease, immunodeficiency, pancreas insufficiency, acute cancers within last 3 years except basal cell carcinoma of the skin, etc.)
  • •A significant CVD event within last 3 mo. incl. myocardial infarction, stroke, congestive heart failure
  • •Regular intake of drugs possibly interfering with this study (e.g. antidepressants, soporifics) within 3 months prior to study start or during study (stable and controlled L-Thyroxin intake would be allowed)
  • •Regular intake of supplements possibly interfering with this study (e.g. cannabidiol, St. John's wort, melatonin, dietary fiber supplements, probiotics etc.) within 4 weeks prior to study start or during the study (stable vitamin D intake would be allowed)
  • •Vegan nutrition
  • •Smoker > 10 cigarettes / day
  • •Blood donation 4 weeks prior to screening visit and during the study
  • •Known pregnancy, breast feeding or intention to become pregnant during the study
  • •Alcohol or drug abuse
  • •Participation in another clinical study within the last 4 weeks and concurrent participation in another clinical study
  • •Relevant allergy or known hypersensitivity against compounds of the study products
  • •Subjects considered inappropriate for the study by investigators, including subjects who are unable or unwilling to show compliance with the protocol

Arms & Interventions

Phytoglycogen

Active Comparator

Phytoglycogen

Intervention: Phytoglycogen (Dietary Supplement)

Placebo

Placebo Comparator

Microcrystalline cellulose

Intervention: Placebo (Dietary Supplement)

Outcomes

Primary Outcomes

Impact on perceived stress (PSQ20)

Time Frame: 8 weeks

* PSQ = perceived stress questionnaire; * higher scores indicate higher stress levels * the value range is 0-100

Secondary Outcomes

  • Impact on perceived stress (PSQ20)(4 weeks)
  • Impact on mood (ASTS+VT)(8 weeks)
  • Impact on sleep (Sleep Questionnaire B/R)(8 weeks)
  • Impact on quality of life (SF-36)(8 weeks)
  • Global Assessment(8 weeks)
  • Blood biomarker(8 weeks)
  • Impact on emotions (App evaluating emotions)(8 weeks)
  • Impact on mood (ASTS+VT)(4 weeks)

Investigators

Sponsor
Mibelle AG
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials